Reference
Tsirigotis P, et al. Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation. Bone Marrow Transplantation 51: 1313-1317, No. 10, Oct 2016. Available from: URL: http://doi.org/10.1038/bmt.2016.129 - Greece
Rights and permissions
About this article
Cite this article
Brentuximab vedotin. Reactions Weekly 1630, 40 (2016). https://doi.org/10.1007/s40278-016-23564-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-23564-9